Yuen So

Publication Details

  • High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.

    Lin PT, Martin BA, Weinacker AB, So YT. Muscle Nerve. 2006; 33 (3): 433-5

    We describe a 48-year-old woman with seronegative myasthenia gravis (MG) and high-titer of anti-MuSK antibody. She had severe bulbar and respiratory weakness with minimal limb weakness for 2 years. Her disease responded poorly to all the conventional immunosuppressive regimens. Treatment with immunoablative dose of cyclophosphamide led to dramatic and sustained remission of her symptoms. High-dose cyclophosphamide is an effective alternative in patients with unusually refractory disease.

    PubMedID: 16116645

Stanford Medicine Resources:

Footer Links: